Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
Total transaction value of the divestment is Rs. 3,660 million
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Advances Amgen's mission to serve patients with rare disease medicines
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Subscribe To Our Newsletter & Stay Updated
